Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,610.00
Bid: 1,610.00
Ask: 1,610.50
Change: -156.50 (-8.86%)
Spread: 0.50 (0.031%)
Open: 1,616.50
High: 1,621.00
Low: 1,589.50
Prev. Close: 1,766.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday broker round-up UPDATE

Thu, 03rd Apr 2014 09:05

Associated British Foods: Citi increases target price from 2350p to 3000p, while its neutral rating remains unchanged.Booker Group: Investec shifts target price from 172p to 178p retaining a buy recommendation.BSkyB: HSBC Holdings moves target price from 600p to 610p, while keeping its underweight rating.Burberry: Deutsche Bank cuts target price from 1600p to 1575p maintaining its hold recommendation.CSR: N+1 Singer raises target price to 777p and reiterates its hold recommendation.Daily Mail & General Trust: Jefferies increases target price from 800p to 1016p and maintains a buy recommendation.Direct Line Group: Berenberg ups target price from 230p to 254p and keeps a hold recommendation.easyJet: JP Morgan raises target price from 1725p to 1965p and reiterates an overweight rating.First Group: JP Morgan lowers target price from 165p to 156p and keeps an overweight rating.Glaxo Smith Kline: JP Morgan reduces target price from 1750p to 1700p leaving its neutral rating unchanged.Greene King: JP Morgan lowers target price from 960p to 940p maintaining a neutral rating.Heritage Oil: UBS reduces target price from 325p to 300p, while its buy recommendation is kept.HSBC Holdings: Investec reduces target price from 745p to 640p and downgrades from buy to hold.Hyder Consulting: Investec upgrades from hold to buy with a target price of 510p.Ithaca Energy: Canaccord Genuity lowers target price from 180p to 175p, while its buy recommendation is kept.Lonmin: RBC Capital cuts target price from 370p to 360p and retains an outperform rating.Marston's: JP Morgan reduces target price from 180p to 155p staying with its neutral rating.McBride: Investec places both its target price (prev.: 120p) and its buy recommendation under review. Panmure Gordon cuts target price from 120p to 100p downgrading from buy to hold.Merlin Entertainment: Deutsche Bank raises target price from 395p to 430p and stays with its buy recommendation.Minoan Group: WH Ireland shifts target price from 20p to 28p and stays with its speculative buy recommendation.Mitchells & Butlers: JP Morgan increases target price from 460p to 530p upgrading to overweight.Parkmead Group: Westhouse Securities initiates with a target price of 400p and a buy recommendation.Pennon Group: UBS takes target price from 725p to 795p and reiterates a buy recommendation.Polymetal International: Citi lowers target price from 452p to 450p and stays with its sell recommendation.Resolution: Canaccord Genuity reduces target price from 375p to 300p maintaining a hold recommendation.Restaurant Group: JP Morgan shifts target price from 750p to 755p retaining an overweight rating.Rotork: RBC Capital initiates with a target price of 2800p and a neutral rating.Severn Trent: UBS takes target price from 1825p to 1885p leaving its neutral rating unaltered.Smith & Nephew: Numis downgrades from add to hold with a target price of 1000p.Spirax-Sarco Engineering: RBC Capital initiates with a target price of 3250p and an outperform rating.Tullow Oil: UBS cuts target price from 925p to 900p, while upgrading from neutral to buy.United Utilities: UBS ups target price from 750p to 775p keeping a neutral rating.Wincanton: Investec upgrades from hold to buy with a target price of 155p.
More News
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more
11 Oct 2023 07:47

LONDON BRIEFING: Stocks lower; GSK settles Zantac case in California

(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.

Read more
9 Oct 2023 08:16

TOP NEWS: GSK inks agreement with Zhifei to promote shingles vaccine

(Alliance News) - GSK PLC on Monday said it has reached an exclusive agreement with Chongqing Zhifei Biological Products Ltd to co-promote its shingles vaccine, Shingrix, in China.

Read more
9 Oct 2023 07:42

LONDON BRIEFING: Metro Bank secures deal to shore up finances

(Alliance News) - Stocks in London are set to open higher on Monday as interest rate expectations held steady despite Friday's bumper US nonfarm payrolls report.

Read more
9 Oct 2023 07:20

GSK inks deal to promote shingles vaccine in China

(Sharecast News) - GSK has entered into a new exclusive vaccine partnership in China that will extend the availability of its shingle vaccine Shingrix, which will see the UK-listed group generate £2.5bn over the next three years.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.